Morbidity associated with oral corticosteroids in patients with severe asthma

被引：12
作者：
Choo, Xue Ning [1 ]
Pavord, Ian D. [1 ]
机构：
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, NDM Res Bldg,Old Rd Campus, Oxford OX3 7FZ, England
来源：
THORAX | 2016年 / 71卷 / 04期
关键词：
RANDOMIZED CONTROLLED-TRIAL; SEVERE EOSINOPHILIC ASTHMA; EXHALED NITRIC-OXIDE; ADVERSE EVENTS; ECONOMIC-IMPLICATIONS; RHEUMATOID-ARTHRITIS; CUMULATIVE BURDEN; DOUBLE-BLIND; MEPOLIZUMAB; PLACEBO;
D O I：
10.1136/thoraxjnl-2015-208242
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：302 / 304
页数：3
相关论文
共 50 条
  • [31] Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
    Khatri, Sumita
    Moore, Wendy
    Gibson, Peter G.
    Leigh, Richard
    Bourdin, Arnaud
    Maspero, Jorge
    Barros, Manuel
    Buhl, Roland
    Howarth, Peter
    Albers, Frank C.
    Bradford, Eric S.
    Gilson, Martyn
    Price, Robert G.
    Yancey, Steven W.
    Ortega, Hector
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (05) : 1742 - +
  • [32] Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
    Gibson, Peter G.
    Prazma, Charlene M.
    Chupp, Geoffrey L.
    Bradford, Eric S.
    Forshag, Mark
    Mallett, Stephen A.
    Yancey, Steve W.
    Smith, Steven G.
    Bel, Elisabeth H.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [33] Different endotypes and phenotypes drive the heterogeneity in severe asthma
    McDowell, P. Jane
    Heaney, Liam G.
    ALLERGY, 2020, 75 (02) : 302 - 310
  • [34] Personalized Medicine in Severe Asthma: From Biomarkers to Biologics
    Chen, Chun-Yu
    Wu, Kang-Hsi
    Guo, Bei-Cyuan
    Lin, Wen-Ya
    Chang, Yu-Jun
    Wei, Chih-Wei
    Lin, Mao-Jen
    Wu, Han-Ping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [35] Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma
    Alamoudi, Asma
    Petralia, Lorenzo
    Smith, Nicholas M. J.
    Xu, Haopeng
    Sandhu, Dominic
    Richmond, Graham
    Talbot, Nick P.
    Ritchie, Grant A. D.
    Pavord, Ian
    Robbins, Peter A.
    Petousi, Nayia
    BMJ OPEN RESPIRATORY RESEARCH, 2025, 12 (01)
  • [36] What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz, Steven
    Oppenheimer, John
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 116 (05) : 383 - 387
  • [37] "As-Needed" Inhaled Corticosteroids for Patients With Asthma
    Cardet, Juan Carlos
    Papi, Alberto
    Reddel, Helen K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03) : 726 - 734
  • [38] Patients with Severe Asthma: Analysis of Future Risks
    Parveen, Sajida
    Zafar, Ghufran
    Nosheen, Rukhshanda
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (05): : 893 - 897
  • [39] The role of systemic corticosteroids in severe asthma and new evidence in their management and tapering
    Menzella, Francesco
    Ghidoni, Giulia
    Fontana, Matteo
    Capobelli, Silvia
    Livrieri, Francesco
    Castagnetti, Claudia
    Facciolongo, Nicola
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (12) : 1283 - 1299
  • [40] Rational oral corticosteroid use in adult severe asthma: A narrative review
    Chung, Li Ping
    Upham, John W.
    Bardin, Philip G.
    Hew, Mark
    RESPIROLOGY, 2020, 25 (02) : 161 - 172
12345